| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Donanemab (Kisunla) | 2026-08-03 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Lunsotogene parvec-cwha (Otarmeni) | 2026-08-03 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Narsoplimab-wuug (Yartemlea) | 2026-08-03 |
| BCBS Highmark Penn Medicare Advantage | Experimental/Investigational Services | 2026-08-03 |
| BCBS Highmark Penn Medicare Advantage | Golimumab (Simponi, Simponi Aria) and Golimumab Biosimilars (Immgolis, Immgolis Intri) | 2026-08-03 |
| BCBS Highmark Penn Medicare Advantage | Narsoplimab-wuug (Yartemlea) | 2026-08-03 |
| BCBS Highmark Penn Medicare Advantage | Pivekimab Sunirine-pvzy (Decnupaz) | 2026-08-03 |
| BCBS Highmark Delaware | Exagamglogene autotemcel (Casgevy) | 2026-08-03 |
| BCBS Highmark Delaware | Pivekimab Sunirine-pvzy (Decnupaz) | 2026-08-03 |
| BCBS Highmark Delaware | Lunsotogene parvec-cwha (Otarmeni) | 2026-08-03 |